Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Cariban for nausea and vomiting of pregnancy
2023-505144-19-00Phase 4Completed
- Sponsor
- ITF Research Pharma
- Start
- Sep 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of Cariban in nausea and vomiting of pregnancy (NVP), sponsored by ITF Research Pharma. Primary endpoint: Change in NVPQoL global score from baseline to Day 14. Started Sep 2023; status: completed.
02
Drugs
Cariban
03
Conditions
nausea and vomiting of pregnancy (NVP)
Beyond the preview
Go deeper on 2023-505144-19-00.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2023-505144-19-00.